The Institute of Medicine has released four recommendations urging significant changes in how clinical trial data are shared, reports Modern Healthcare. 

IOM's recommendations are as follows:

1. Data sharing should be the expectation and the norm.

2. A fully analyzable set of data should be available no later than 18 months after a study's completion.

3. Strategies should be implemented to encourage data sharing, including the creation of technological platforms, boosting financial support and creating incentives.

4. The fourth recommendation calls ons sponsors of a study to take the lead on making the recommendations happen.

Read more below: